Novel CETSA HT assays are described for two important oncology targets, B-Raf and PARP1, and applied to both primary screening for hit identification and SAR screening for lead optimization.

An evaluation of high-throughput CETSA for hit identification and SAR screening with comparisons to alternative assay formats demonstrates the technology can be robustly and reliably applied ...